![Neeraj Agarwal, MD, FASCO(@neerajaiims) 's Twitter Profileg](https://pbs.twimg.com/profile_images/1179881343674654720/uWRt5o3R_200x200.jpg)
Neeraj Agarwal, MD, FASCO
@neerajaiims
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/ywWAdZmBWt
ID:4761682514
https://bit.ly/3JApRJd 15-01-2016 06:32:10
12,9K Tweets
14,7K Followers
786 Following
Follow People
![Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1584135535718797312/bXTLR8Jz_200x200.jpg)
🔶PSA screening rates 📉 among men aged 40 years or older in the US Veterans Health Administration
🔶Facilities with higher PSA screening rates had lower subsequent rates of metastatic #prostatecancer
JAMA Oncology OncoAlert Prostate Cancer Foundation European Association of Urology (EAU) ASCO National Comprehensive Cancer Network (NCCN)
jamanetwork.com/journals/jamao…
![Yüksel Ürün (@DrYukselUrun) on Twitter photo 2022-10-24 21:20:45 🔶PSA screening rates 📉 among men aged 40 years or older in the US Veterans Health Administration 🔶Facilities with higher PSA screening rates had lower subsequent rates of metastatic #prostatecancer @JAMAOnc @OncoAlert @PCFnews @Uroweb @ASCO @NCCN jamanetwork.com/journals/jamao… 🔶PSA screening rates 📉 among men aged 40 years or older in the US Veterans Health Administration 🔶Facilities with higher PSA screening rates had lower subsequent rates of metastatic #prostatecancer @JAMAOnc @OncoAlert @PCFnews @Uroweb @ASCO @NCCN jamanetwork.com/journals/jamao…](https://pbs.twimg.com/media/Ff3TwgyXoAAgKI-.png)
![Neli Ulrich, PhD(@NeliMUlrich) 's Twitter Profile Photo Neli Ulrich, PhD(@NeliMUlrich) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1281439115309748227/OOFhF5l9_200x200.jpg)
Congratulations Jonathan (the ultimate Jonathan Tward) to your innovative research using deep learning in digital histopathology! University of Utah Radiation Oncology Huntsman Cancer Institute GU Cancer Research Program @HuntsmanCancer Neeraj Agarwal
![ASTRO(@ASTRO_org) 's Twitter Profile Photo ASTRO(@ASTRO_org) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1425087330654752774/vDdiQ9Qj_200x200.jpg)
![Dra. María Natalia Gandur Quiroga(@nataliagandur) 's Twitter Profile Photo Dra. María Natalia Gandur Quiroga(@nataliagandur) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1541027400447844352/9k4tpmnY_200x200.jpg)
💫Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA
Umang Swami
Sumanta Pal
Neeraj Agarwal
OncoAlert
OncoReporte frontiersin.org/articles/10.33…
![OncoAlert(@OncoAlert) 's Twitter Profile Photo OncoAlert(@OncoAlert) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1215669650333323266/z8agvcHA_200x200.jpg)
Dear #ASTRO22 ASTRO ⭐️
We're OncoAlert🚨
Gil Morgan
Toni Choueiri, MD Vivek Subbiah, MD Neeraj Agarwal Darcy Burbage, DNP, RN, AOCN J. De Munter Jill Feldman Mark Lewis Andreas Charalambous Stephen V Liu, MD Matteo Lambertini, MD PhD Dr. Cathy Eng Icro Meattini Yelena Y. Janjigian MD LENA SHARP Tom Powles Rana McKay
![OncoAlert (@OncoAlert) on Twitter photo 2022-10-24 12:02:56 Dear #ASTRO22 @ASTRO_org ⭐️ We're OncoAlert🚨 @weoncologists @DrChoueiri @VivekSubbiah @neerajaiims @DarcyBurbage @Jdmunter1 @jillfeldman4 @marklewismd @AndreasC466 @StephenVLiu @matteolambe @CathyEngMD @Icro_Meattini @YJanjigianMD @sharp_lena @tompowles1 @DrRanaMcKay Dear #ASTRO22 @ASTRO_org ⭐️ We're OncoAlert🚨 @weoncologists @DrChoueiri @VivekSubbiah @neerajaiims @DarcyBurbage @Jdmunter1 @jillfeldman4 @marklewismd @AndreasC466 @StephenVLiu @matteolambe @CathyEngMD @Icro_Meattini @YJanjigianMD @sharp_lena @tompowles1 @DrRanaMcKay](https://pbs.twimg.com/media/Ff1Q3kLXEAARFDO.jpg)
![Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo Yüksel Ürün(@DrYukselUrun) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1584135535718797312/bXTLR8Jz_200x200.jpg)
Does timing ⏳ matter?
When short-term ADT is used with prostate-only radiation ☢️ , concurrent/adjuvant ADT should be the standard of care. #prostatecancer
Amar Kishan Daniel E Spratt Journal of Clinical Oncology APCCC22 ASCO ESMO - Eur. Oncology OncoAlert UroToday.com European Association of Urology (EAU)
![Yüksel Ürün (@DrYukselUrun) on Twitter photo 2022-10-22 10:50:04 Does timing ⏳ matter? When short-term ADT is used with prostate-only radiation ☢️ , concurrent/adjuvant ADT should be the standard of care. #prostatecancer @AmarUKishan @DrSpratticus @JCO_ASCO @APCCC_Lugano @ASCO @myESMO @OncoAlert @urotoday @Uroweb Does timing ⏳ matter? When short-term ADT is used with prostate-only radiation ☢️ , concurrent/adjuvant ADT should be the standard of care. #prostatecancer @AmarUKishan @DrSpratticus @JCO_ASCO @APCCC_Lugano @ASCO @myESMO @OncoAlert @urotoday @Uroweb](https://pbs.twimg.com/media/Ffqw2HlWIAAK_-_.jpg)
![Thomas Flaig(@TomFlaigMD) 's Twitter Profile Photo Thomas Flaig(@TomFlaigMD) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1534668252021936128/-wnO00GD_200x200.jpg)
Sarmad Sadeghi presents on phase III S1937 trial at the fall SWOG Cancer Research Network meeting. An important trial evaluating eribulin +/- gemcitabine as subsequent line therapy for metastatic urothelial carcioma.
swog.org/clinical-trial…
![Thomas Flaig (@TomFlaigMD) on Twitter photo 2022-10-22 20:41:42 Sarmad Sadeghi presents on phase III S1937 trial at the fall @SWOG meeting. An important trial evaluating eribulin +/- gemcitabine as subsequent line therapy for metastatic urothelial carcioma. swog.org/clinical-trial… Sarmad Sadeghi presents on phase III S1937 trial at the fall @SWOG meeting. An important trial evaluating eribulin +/- gemcitabine as subsequent line therapy for metastatic urothelial carcioma. swog.org/clinical-trial…](https://pbs.twimg.com/media/Ffs4P7_XwAACUcY.jpg)
![OncoAlert(@OncoAlert) 's Twitter Profile Photo OncoAlert(@OncoAlert) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1215669650333323266/z8agvcHA_200x200.jpg)
What happens in Greece..Stays in Greece🇬🇷
So Not True‼️
Very Proud to announce that we are taking with us a NEW OncoAlert🚨Faculty🌐
A warm welcome to the awesome Tom Powles 🇬🇧and beyond honoured to have him in the Network🙌
![OncoAlert (@OncoAlert) on Twitter photo 2022-10-22 09:30:40 What happens in Greece..Stays in Greece🇬🇷 So Not True‼️ Very Proud to announce that we are taking with us a NEW OncoAlert🚨Faculty🌐 A warm welcome to the awesome @tompowles1 🇬🇧and beyond honoured to have him in the Network🙌 What happens in Greece..Stays in Greece🇬🇷 So Not True‼️ Very Proud to announce that we are taking with us a NEW OncoAlert🚨Faculty🌐 A warm welcome to the awesome @tompowles1 🇬🇧and beyond honoured to have him in the Network🙌](https://pbs.twimg.com/media/Ffqd39GWAAMpDOz.jpg)
![Sumanta Pal(@montypal) 's Twitter Profile Photo Sumanta Pal(@montypal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1148507918808993793/SmRHi-_U_200x200.jpg)
Beautiful talk by Parminder singh at the 1st #Vogelzang SWOG Cancer Research Network Symposium. He highlights the common elements of successful studies (simple eligibility, simple design) w examples from Neeraj Agarwal (S1216), Thomas Flaig (S1314) & his own study (S1806) w Peter Black.
![Sumanta Pal (@montypal) on Twitter photo 2022-10-21 15:06:46 Beautiful talk by @Parminder1699 at the 1st #Vogelzang @SWOG Symposium. He highlights the common elements of successful studies (simple eligibility, simple design) w examples from @neerajaiims (S1216), @TomFlaigMD (S1314) & his own study (S1806) w @pcvblack. Beautiful talk by @Parminder1699 at the 1st #Vogelzang @SWOG Symposium. He highlights the common elements of successful studies (simple eligibility, simple design) w examples from @neerajaiims (S1216), @TomFlaigMD (S1314) & his own study (S1806) w @pcvblack.](https://pbs.twimg.com/media/FfmiAkwWAAASjeI.jpg)
![Sumanta Pal(@montypal) 's Twitter Profile Photo Sumanta Pal(@montypal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1148507918808993793/SmRHi-_U_200x200.jpg)
Hope to see many of you this AM at this SWOG Cancer Research Network symposium dedicated to our dear friend/mentor/colleague #NickVogelzang . It was National Cancer Institute cooperative group mtgs that brought us together; through them his legacy will live on. Daniel Petrylak Neelima Denduluri Neeraj Agarwal Ulka Vaishampayan
![Sumanta Pal (@montypal) on Twitter photo 2022-10-21 10:05:12 Hope to see many of you this AM at this @SWOG symposium dedicated to our dear friend/mentor/colleague #NickVogelzang. It was @theNCI cooperative group mtgs that brought us together; through them his legacy will live on. @DanielPetrylak @ndenduluri1 @neerajaiims @DrVaishampayan Hope to see many of you this AM at this @SWOG symposium dedicated to our dear friend/mentor/colleague #NickVogelzang. It was @theNCI cooperative group mtgs that brought us together; through them his legacy will live on. @DanielPetrylak @ndenduluri1 @neerajaiims @DrVaishampayan](https://pbs.twimg.com/media/Fflc_UsXwAARvbn.jpg)
![OncoAlert(@OncoAlert) 's Twitter Profile Photo OncoAlert(@OncoAlert) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1215669650333323266/z8agvcHA_200x200.jpg)
The amazing Petros Grivas 🇬🇷knocks it out of the park at the 3rd Athenian Oncology Congress‼️
#IO in advanced Urothelial cancer
Chairs Marita Lykka MD & Marinos Tsiatas
![OncoAlert (@OncoAlert) on Twitter photo 2022-10-22 14:34:39 The amazing @PGrivasMDPhD 🇬🇷knocks it out of the park at the 3rd Athenian Oncology Congress‼️ #IO in advanced Urothelial cancer Chairs @marilykmd & @mtsiatas The amazing @PGrivasMDPhD 🇬🇷knocks it out of the park at the 3rd Athenian Oncology Congress‼️ #IO in advanced Urothelial cancer Chairs @marilykmd & @mtsiatas](https://pbs.twimg.com/media/FfrkP8VXkAEsC2P.jpg)
![Sumanta Pal(@montypal) 's Twitter Profile Photo Sumanta Pal(@montypal) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1148507918808993793/SmRHi-_U_200x200.jpg)
Excited to see progress w SWOG Cancer Research Network Clinical Trial Partnerships, w exceptional leadership from #DrKathyAlbain . I've been doing peer reviews & seen some incredible designs come thru! I spy #DrBlanke , Manmeet Ahluwalia, MD, MBA & others in the audience. Joining virtually today but onsite tomorrow!
![Sumanta Pal (@montypal) on Twitter photo 2022-10-20 17:37:35 Excited to see progress w @SWOG Clinical Trial Partnerships, w exceptional leadership from #DrKathyAlbain. I've been doing peer reviews & seen some incredible designs come thru! I spy #DrBlanke, @BrainTumorDoc & others in the audience. Joining virtually today but onsite tomorrow! Excited to see progress w @SWOG Clinical Trial Partnerships, w exceptional leadership from #DrKathyAlbain. I've been doing peer reviews & seen some incredible designs come thru! I spy #DrBlanke, @BrainTumorDoc & others in the audience. Joining virtually today but onsite tomorrow!](https://pbs.twimg.com/media/Ffh5MejUYAACuHu.png)
![Toni Choueiri, MD(@DrChoueiri) 's Twitter Profile Photo Toni Choueiri, MD(@DrChoueiri) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/693093012025561088/tgX3Norh_200x200.jpg)
JUST IN: Cytoreductive Nephrectomy for Metastatic RCC Treated with Immune Checkpoint Inhibitors or Targeted Therapy: The IMDC does it again ! #IMDC Daniel Heng with Talal El Zarif, MD Ziad Bakouny, MD, MSc Shaan Dudani et al in European Urology
secure-web.cisco.com/1nOqqWr2rKW30O…
![Toni Choueiri, MD (@DrChoueiri) on Twitter photo 2022-10-20 05:30:24 JUST IN: Cytoreductive Nephrectomy for Metastatic RCC Treated with Immune Checkpoint Inhibitors or Targeted Therapy: The @IMDConline does it again ! #IMDC @DrDanielHeng with @TalalZarif1 @ZiadBakouny @ShaanDudani et al in @EUplatinum secure-web.cisco.com/1nOqqWr2rKW30O… JUST IN: Cytoreductive Nephrectomy for Metastatic RCC Treated with Immune Checkpoint Inhibitors or Targeted Therapy: The @IMDConline does it again ! #IMDC @DrDanielHeng with @TalalZarif1 @ZiadBakouny @ShaanDudani et al in @EUplatinum secure-web.cisco.com/1nOqqWr2rKW30O…](https://pbs.twimg.com/media/FffUf3xWQAAvzrB.jpg)
![Neli Ulrich, PhD(@NeliMUlrich) 's Twitter Profile Photo Neli Ulrich, PhD(@NeliMUlrich) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1281439115309748227/OOFhF5l9_200x200.jpg)
This is SO amazing!!! Three nominees from Huntsman Cancer Institute were honored with this year's Cancer Community Awards!!! Congratulations to David Wetter, Doug Fair, and Charles R. Rogers, PhD, MPH, MS, MCHES! This fully attests to the work we do here, dedicated to the communities we serve! HCI Community Outreach and Engagement University of Utah
![Vivek Subbiah, MD(@VivekSubbiah) 's Twitter Profile Photo Vivek Subbiah, MD(@VivekSubbiah) 's Twitter Profile Photo](https://pbs.twimg.com/profile_images/1097689560442642432/gDbq9r2-_200x200.jpg)